Kenneth C. Frazier

Chairman and Chief Executive Officer, Merck Sharp & Dohme.

A lawyer by training, Ken joined MSD in 1992 as general counsel. He held a range of senior management positions before being appointed CEO in 2011. In 2018, Ken was named on the Time 100 most influential people list for his decision to leave President Trump’s manufacturing council.

Part of the Power List 2019

Breakthroughs at the bench, novel technologies and groundbreaking policies and regulation have helped the pharma industry grow from strength to strength. After months of collating reader nominations and judging overseen by a panel of industry experts, we proudly present The Medicine Maker 2019 Power List, featuring 100 of the industry’s pioneers across four categories: Industry Influencers, Business Captains, Masters of the Bench, and Champions of Change.

Go to The Power List 2019